Edition:
United Kingdom

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

10.25USD
18 Jan 2018
Change (% chg)

$0.05 (+0.49%)
Prev Close
$10.20
Open
$10.23
Day's High
$10.28
Day's Low
$9.97
Volume
16,455
Avg. Vol
66,655
52-wk High
$17.33
52-wk Low
$8.86

Select another date:

Mon, Jan 8 2018

BRIEF-Seres Therapeutics Says Has Cash, Cash Equivalents And Investments Of $171.3 Mln

* SERES THERAPEUTICS SAYS HAS CASH, CASH EQUIVALENTS AND INVESTMENTS OF $171.3 MILLION, AS OF SEPT 30, 2017 - SEC FILING Source text: (http://bit.ly/2qFSBN0) Further company coverage:

BRIEF-Seres Therapeutics Announces FDA Orphan Drug Designation For SER-287 In Treatment Of Pediatric Ulcerative Colitis

* SERES THERAPEUTICS ANNOUNCES FDA ORPHAN DRUG DESIGNATION FOR SER-287 IN TREATMENT OF PEDIATRIC ULCERATIVE COLITIS

BRIEF-Seres Therapeutics Q2 net loss $28 million

* Seres therapeutics reports second quarter 2017 financial results and provides update on operational progress

Select another date: